Cognitive Risks of Anticholinergics in the Elderly

• Tune L , CarrS, HoagE, CooperT. Anticholinergic effects of drugs commonly prescribed for the elderly: potential means for assessing risk of delirium. Am. J. Psychiatry149(10), 1393–1394(1992).
   PubMed Web of Science ®Google Scholar
• Chew ML , MulsantBH, PollockBGet al. Anticholinergic activity of 107 medications commonly used by older adults. J. Am.Geriatr. Soc. 56(7), 1333–1341(2008).
   PubMed Web of Science ®Google Scholar
• Han L , McCuskerJ, ColeM, AbrahamowiczM, PrimeauF, ElieM. Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients. Arch. Intern. Med.161(8), 1099–1105(2001).
   PubMedGoogle Scholar
• Gerretsen P , PollockBG. Drugs with anticholinergic properties: a current perspective on use and safety. Expert Opin. Drug Saf.10(5), 751–765(2011).
   PubMed Web of Science ®Google Scholar
• Modi A , WeinerM, CraigBA, SandsLP, RosenmanMB, ThomasJ 3rd. Concomitant use of anticholinergics with acetylcholinesterase inhibitors in Medicaid recipients with dementia and residing in nursing homes. J. Am. Geriatr. Soc.57(7), 1238–1244(2009).
   PubMed Web of Science ®Google Scholar
• Mulsant BH , PollockBG, KirshnerM, ShenC, DodgeH, GanguliM. Serum anticholinergic activity in a community-based sample of older adults: relationship with cognitive performance. Arch. Gen. Psychiatry60(2), 198–203(2003).
   PubMed Web of Science ®Google Scholar
• Gerretsen P , PollockBG. Rediscovering adverse anticholinergic effects. J. Clin. Psychiatry72(6), 869–870(2011).
   PubMed Web of Science ®Google Scholar
• Raedler TJ , BymasterFP, TandonR, CopolovD, DeanB. Towards a muscarinic hypothesis of schizophrenia. Mol. Psychiatry12(3), 232–246(2007).
   PubMed Web of Science ®Google Scholar
• Sarter M , ParikhV. Choline transporters, cholinergic transmission and cognition. Nat. Rev. Neurosci.6(1), 48–56(2005).
   PubMed Web of Science ®Google Scholar
• Mesulam MM . The cholinergic innervation of the human cerebral cortex. Prog. Brain Res.145, 67–78(2004).
   PubMed Web of Science ®Google Scholar
• Barak S . Modeling cholinergic aspects of schizophrenia: focus on the antimuscarinic syndrome. Behav. Brain Res.204(2), 335–351(2009).
   PubMed Web of Science ®Google Scholar
• Canadian Pharmacists Association. Compendium of Pharmaceuticals and Specialties: the Canadian Drug Reference for Health Professionals (2007 Edition). Canadian Pharmacists Association, ON, Canada (2007).
   Google Scholar
• Abrams P , CardozoL, FallMet al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Am. J. Obstet. Gynecol. 187(1), 116–126(2002).
   PubMed Web of Science ®Google Scholar
• Milsom I , AbramsP, CardozoL, RobertsRG, ThuroffJ, WeinAJ. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int.87(9), 760–766(2001).
   PubMed Web of Science ®Google Scholar
• Schweitzer P , MarkH. The effect of atropine on cardiac arrhythmias and conduction. Part 2. Am. Heart J.100(2), 255–261(1980).
   PubMed Web of Science ®Google Scholar
• Schweitzer P , MarkH. The effect of atropine on cardiac arrhythmias and conduction. Part 1. Am. Heart J.100(1), 119–127(1980).
   PubMed Web of Science ®Google Scholar
• Leon C , GerretsenP, UchidaH, SuzukiT, RajjiT, MamoDC. Sensitivity to antipsychotic drugs in older adults. Curr. Psychiatry Rep.12(1), 28–33(2010).
   PubMed Web of Science ®Google Scholar
• Schliebs R , ArendtT. The cholinergic system in aging and neuronal degeneration. Behav. Brain Res.221(2), 555–563(2011).
   PubMed Web of Science ®Google Scholar
• Brenner SS , KlotzU. P-glycoprotein function in the elderly. Eur. J. Clin. Pharmacol.60(2), 97–102(2004).
   PubMed Web of Science ®Google Scholar
• Wong DF , WagnerHN Jr, Dannals RF et al. Effects of age on dopamine and serotonin receptors measured by positron tomography in the living human brain. Science226(4681), 1393–1396(1984).
   PubMed Web of Science ®Google Scholar
• Burke SN , BarnesCA. Neural plasticity in the ageing brain. Nat. Rev. Neurosci.7(1), 30–40(2006).
   PubMed Web of Science ®Google Scholar
• Bartus RT . On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis. Exp. Neurol.163(2), 495–529(2000).
   PubMed Web of Science ®Google Scholar
• Bartus RT , DeanRL 3rd, Beer B, Lippa AS. The cholinergic hypothesis of geriatric memory dysfunction. Science217(4558), 408–414(1982).
   PubMed Web of Science ®Google Scholar
• Fibiger HC . Cholinergic mechanisms in learning, memory and dementia: a review of recent evidence. Trends Neurosci.14(6), 220–223(1991).
   PubMed Web of Science ®Google Scholar
• Mufson EJ , GinsbergSD, IkonomovicMD, DekoskyST. Human cholinergic basal forebrain: chemoanatomy and neurologic dysfunction. J. Chem. Neuroanat.26(4), 233–242(2003).
   PubMed Web of Science ®Google Scholar
• Whitehouse PJ , PriceDL, StrubleRG, ClarkAW, CoyleJT, DelonMR. Alzheimer‘s disease and senile dementia: loss of neurons in the basal forebrain. Science215(4537), 1237–1239(1982).
   PubMed Web of Science ®Google Scholar
• Chew ML , MulsantBH, PollockBG. Serum anticholinergic activity and cognition in patients with moderate-to-severe dementia. Am. J. Geriatr. Psychiatry13(6), 535–538(2005).
   PubMed Web of Science ®Google Scholar
• Rovner BW , DavidA, Lucas-BlausteinMJ, ConklinB, FilippL, TuneL. Self-care capacity and anticholinergic drug levels in nursing home patients. Am. J. Psychiatry145(1), 107–109(1988).
   PubMed Web of Science ®Google Scholar
• Cancelli I , ValentinisL, MerlinoG, ValenteM, GigliGL. Drugs with anticholinergic properties as a risk factor for psychosis in patients affected by Alzheimer‘s disease. Clin. Pharmacol. Ther.84(1), 63–68(2008).
   PubMed Web of Science ®Google Scholar
• Lu CJ , TuneLE. Chronic exposure to anticholinergic medications adversely affects the course of Alzheimer disease. Am. J. Geriatr. Psychiatry11(4), 458–461(2003).
   PubMed Web of Science ®Google Scholar
• Nebes R , PollockBG, MulsantBHet al. Low-level serum anticholinergicity as a source of baseline cognitive heterogeneity in geriatric depressed patients. Psychopharmacol. Bulletin 33, 715–720(1997).
   PubMed Web of Science ®Google Scholar
• Cancelli I , GigliGL, PianiAet al. Drugs with anticholinergic properties as a risk factor for cognitive impairment in elderly people: a population-based study. J. Clin. Psychopharmacol. 28(6), 654–659(2008).
   PubMed Web of Science ®Google Scholar
• Carriere I , Fourrier-ReglatA, DartiguesJFet al. Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study. Arch. Intern. Med. 169(14), 1317–1324(2009).
   PubMedGoogle Scholar
• Aizenberg D , SiglerM, WeizmanA, BarakY. Anticholinergic burden and the risk of falls among elderly psychiatric inpatients: a 4-year case–control study. Int. Psychogeriatr.14(3), 307–310(2002).
   PubMed Web of Science ®Google Scholar
• Nebes RD , PollockBG, HalliganEM, KirshnerMA, HouckPR. Serum anticholinergic activity and motor performance in elderly persons. J. Gerontol. A Biol. Sci. Med. Sci.62(1), 83–85(2007).
   PubMed Web of Science ®Google Scholar
• Nebes RD , PollockBG, HalliganEM, HouckP, SaxtonJA. Cognitive slowing associated with elevated serum anticholinergic activity in older individuals is decreased by caffeine use. Am. J. Geriatr. Psychiatry19(2), 169–175(2010).
   Web of Science ®Google Scholar
• Nebes RD , PollockBG, PereraS, HalliganEM, SaxtonJA. The greater sensitivity of elderly APOE epsilon4 carriers to anticholinergic medications is independent of cerebrovascular disease risk. Am. J. Geriatr. Pharmacother.10(3), 185–192(2012).
   PubMedGoogle Scholar
• Uusvaara J , PitkalaKH, TienariPJ, KautiainenH, TilvisRS, StrandbergTE. Association between anticholinergic drugs and apolipoprotein E epsilon4 allele and poorer cognitive function in older cardiovascular patients: a cross-sectional study. J. Am. Geriatr. Soc.57(3), 427–431(2009).
   PubMedGoogle Scholar
• Campbell NL , BoustaniMA, LaneKAet al. Use of anticholinergics and the risk of cognitive impairment in an African American population. Neurology 75(2), 152–159(2010).
   PubMed Web of Science ®Google Scholar
• Mangoni AA , Van Munster BC, Woodman RJ, De Rooij SE. Measures of anticholinergic drug exposure, serum anticholinergic activity, and all-cause postdischarge mortality in older hospitalized patients with hip fractures. Am. J. Geriatr. Psychiatry doi:10.1097/JGP.0b013e3182546182 (2012) (Epub ahead of print).
   Google Scholar
• Hilmer SN , MagerDE, SimonsickEMet al. A drug burden index to define the functional burden of medications in older people. Arch. Intern. Med. 167(8), 781–787(2007).
   PubMedGoogle Scholar
• Carnahan RM , LundBC, PerryPJ, PollockBG, CulpKR. The Anticholinergic Drug Scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity. J. Clin. Pharmacol.46(12), 1481–1486(2006).
   PubMed Web of Science ®Google Scholar
• Kersten H , MoldenE, WillumsenT, EngedalK, WyllerTB. Higher anticholinergic drug scale (ADS) scores are associated with peripheral but not cognitive markers of cholinergic blockade. Cross sectional data from 21 Norwegian nursing homes. Br. J. Clin. Pharmacol.75(3), 842–849(2012).
   Web of Science ®Google Scholar
• Kersten H , MoldenE, ToloIK, SkovlundE, EngedalK, WyllerTB. Cognitive effects of reducing anticholinergic drug burden in a frail elderly population: a randomized controlled trial. J. Gerontol. A Biol. Sci. Med. Sci.68(3), 271–278(2012).
   PubMed Web of Science ®Google Scholar
• Tune L , CoyleJT. Serum levels of anticholinergic drugs in treatment of acute extrapyramidal side effects. Arch. Gen. Psychiatry37(3), 293–297(1980).
   PubMed Web of Science ®Google Scholar
• Vinogradov S , FisherM, WarmH, HollandC, KirshnerMA, PollockBG. The cognitive cost of anticholinergic burden: decreased response to cognitive training in schizophrenia. Am. J. Psychiatry166(9), 1055–1062(2009).
   PubMed Web of Science ®Google Scholar
• Nishtala PS , FoisRA, MclachlanAJ, BellJS, KellyPJ, ChenTF. Anticholinergic activity of commonly prescribed medications and neuropsychiatric adverse events in older people. J. Clin. Pharmacol.49(10), 1176–1184(2009).
   PubMed Web of Science ®Google Scholar
• Carnahan RM , LundBC, PerryPJ, PollockBG. A critical appraisal of the utility of the serum anticholinergic activity assay in research and clinical practice. Psychopharmacol. Bull.36(2), 24–39(2002).
   PubMedGoogle Scholar
• Alzheimer‘s Association. 2012 Alzheimer‘s disease facts and figures. Alzheimers Dement.8(2), 131–168(2012).
   PubMed Web of Science ®Google Scholar
• American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J. Am. Geriatr. Soc.60(4), 616–631(2012).
   PubMed Web of Science ®Google Scholar

Website

• Silvermedia. www.silvermedia.ca
   Google Scholar